Myriam Curet McAdams - 12 Nov 2024 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
EVP & Chief Medical Officer
Signature
By: Donna Spinola For: Curet, Myriam
Issuer symbol
ISRG
Transactions as of
12 Nov 2024
Net transactions value
-$4,559,196
Form type
4
Filing time
13 Nov 2024, 16:21:06 UTC
Previous filing
24 Jul 2024
Next filing
02 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $401,716 +2,257 +757% $177.99 2,555 12 Nov 2024 Direct F1
transaction ISRG Common Stock Sale $1,209,655 -2,257 -88% $535.96 298 12 Nov 2024 Direct F1, F2
transaction ISRG Common Stock Options Exercise $914,166 +5,000 +1678% $182.83 5,298 12 Nov 2024 Direct F1
transaction ISRG Common Stock Sale $2,679,784 -5,000 -94% $535.96 298 12 Nov 2024 Direct F1, F2
transaction ISRG Common Stock Options Exercise $504,429 +2,199 +738% $229.39 2,497 12 Nov 2024 Direct F1
transaction ISRG Common Stock Sale $1,178,569 -2,199 -88% $535.96 298 12 Nov 2024 Direct F1, F2
transaction ISRG Common Stock Options Exercise $837,689 +4,010 +1346% $208.90 4,308 12 Nov 2024 Direct F1
transaction ISRG Common Stock Sale $2,149,187 -4,010 -93% $535.96 298 12 Nov 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,257 -100% $0.000000 0 12 Nov 2024 Common Stock 2,257 $177.99 Direct F1, F3
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -5,000 -100% $0.000000 0 12 Nov 2024 Common Stock 5,000 $182.83 Direct F1, F3
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -4,010 -67% $0.000000 2,005 12 Nov 2024 Common Stock 4,010 $208.90 Direct F1, F4
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,199 -44% $0.000000 2,829 12 Nov 2024 Common Stock 2,199 $229.39 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $533.10 to $538.66 as follows: 4,510 shares sold at $533.10 to $534.07; 907 shares sold at $534.11 to $534.68; 200 shares sold at $535.34 to $536.28; 4,400 shares sold at $536.46 to $537.36; 3,437 shares sold at $537.49 to $538.36; and 12 shares sold at $538.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F4 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
F5 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.